Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Exploratory study of different doses of SAMe in NASH patients and matched healthy volunteers
2012-000975-18Phase 3Completed
- Sponsor
- Abbott Laboratories
- Start
- Jul 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of S-adenosylmethionine in metabolic dysfunction-associated steatohepatitis (MASH) (3 arms), sponsored by Abbott Laboratories. Primary endpoint: Methionine tolerance test (primary). Started Jul 2012; status: completed.
02
Drugs
S-adenosylmethionine
03
Conditions
metabolic dysfunction-associated steatohepatitis (MASH)
Beyond the preview
Go deeper on 2012-000975-18.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2012-000975-18.